How to Get Accutane (Isotretinoin) in South Carolina

What Isotretinoin Is and Why It Requires a Special Program

Isotretinoin is an oral retinoid approved by the FDA for severe, recalcitrant nodular acne that has not responded to systemic antibiotics. Its teratogenicity risk is so severe that the FDA launched the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program, which mandates that prescribers, patients, and pharmacies all register before any prescription can be filled. Strauss et al. first demonstrated isotretinoin's efficacy in a landmark 1984 randomized trial, reporting complete remission in a substantial proportion of nodular-acne patients after a single course. The FDA's current prescribing label carries a black-box warning for fetal exposure, requiring monthly pregnancy testing for patients who can become pregnant, two forms of contraception, and a 30-day prescription limit with no automatic refills.

Beyond teratogenicity, isotretinoin carries well-documented risks of hypertriglyceridemia, transaminase elevation, and mood changes. Those risks are manageable with appropriate monitoring, but they make the lab-and-consent framework non-negotiable regardless of which state you live in.

South Carolina follows all federal iPLEDGE requirements, so the process for a resident of Charleston, Greenville, or Columbia is identical to that in any other state, with one layer of South Carolina-specific telehealth law added on top.

Step 1: Find a Prescriber in South Carolina

Any South Carolina-licensed physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) who has completed iPLEDGE prescriber registration may write isotretinoin prescriptions. Dermatologists handle the large majority of these cases, but primary care physicians and some telehealth providers also prescribe it.

In-person dermatology. Dermatology practices in Columbia, Greenville, Myrtle Beach, and Charleston typically have wait times of 4 to 12 weeks for new patients. The American Academy of Dermatology's Find a Dermatologist tool can locate board-certified providers in your zip code.

Telehealth. South Carolina permits telehealth prescribing of controlled and non-controlled medications when a valid patient-provider relationship exists. Isotretinoin is not a controlled substance, so no in-person visit is required by state law. A synchronous video consultation that includes a structured skin assessment, a complete medical history, and a review of labs satisfies the standard of care for telehealth prescribing in the state. Platforms licensed in South Carolina can send the iPLEDGE-compliant prescription directly to a pharmacy of your choice.

The HealthRX clinical team uses a three-visit telehealth framework for isotretinoin in South Carolina: (1) a pre-lab intake visit to collect history and order baseline labs, (2) a lab-review visit to confirm eligibility and complete iPLEDGE enrollment, and (3) a prescription-issuance visit after the mandatory iPLEDGE waiting period has elapsed. Patients who can become pregnant require a documented negative pregnancy test at each of those visits before the month-28 window opens.

Who can prescribe: MD vs. NP vs. PA. All three provider types may prescribe isotretinoin in South Carolina provided they hold an active state license, maintain iPLEDGE registration, and practice within their scope. NPs in South Carolina operate under a "reduced practice" model, meaning they require a written practice agreement with a supervising physician. PAs also require physician supervision under state law. In telehealth settings, patients should verify that their provider holds an active South Carolina license before the consultation.

Step 2: Complete Required Labs Before Starting

Labs are not optional. The FDA's iPLEDGE program documentation specifies baseline and monthly monitoring requirements, and most South Carolina prescribers follow the American Acne and Rosacea Society protocol as well.

Baseline panel (before starting):

• Complete blood count (CBC) with differential
• Comprehensive metabolic panel (CMP), including AST, ALT, and total bilirubin
• Fasting lipid panel (total cholesterol, LDL, HDL, triglycerides)
• Urine or serum hCG for patients who can become pregnant (must be negative)

Monthly monitoring (during treatment):

• Fasting lipid panel, repeated monthly for the first 3 months, then every 1 to 2 months
• LFTs repeated if baseline is abnormal or the patient uses alcohol
• Pregnancy test for patients who can become pregnant, 30 days after starting and monthly thereafter

A 2021 systematic review in JAMA Dermatology found that clinically meaningful transaminase elevations occurred in roughly 11% of isotretinoin courses, nearly all reversible upon dose reduction or discontinuation. Hypertriglyceridemia exceeding 500 mg/dL occurred in approximately 25% of patients receiving doses above 1 mg/kg/day, which is exactly why the lipid panel cannot be skipped.

For telehealth patients in South Carolina, labs can be ordered through any state-licensed commercial laboratory. Quest Diagnostics and LabCorp both operate draw sites throughout the state. Results are uploaded to the prescriber's chart and reviewed during the lab-review telehealth visit.

Step 3: Enroll in iPLEDGE

The iPLEDGE REMS is a federal program that operates the same way in every state. Enrollment is managed entirely online at ipledgeprogram.com, and both prescribers and patients must have accounts.

For patients who can become pregnant, iPLEDGE requires:

• Two forms of contraception starting 30 days before the first dose and continuing 30 days after the last dose
• A negative pregnancy test 30 days before prescribing and again within 7 days before the first dispensing
• Monthly negative pregnancy tests throughout treatment
• Answers to a monthly contraception counseling questionnaire in the iPLEDGE portal

For patients who cannot become pregnant (including patients assigned male at birth and post-menopausal patients), the process is simpler: registration, a one-time educational quiz, and monthly prescription confirmations in the portal. A 2022 update to iPLEDGE removed the binary gender designations, replacing them with reproductive-risk categories, which improved access for transgender and non-binary patients.

A point often overlooked: after a patient completes the monthly iPLEDGE requirements, there is a 7-day dispensing window for patients who can become pregnant. If the prescription is not picked up or shipped within that window, the patient must restart the monthly qualification process. Planning ahead with your pharmacy before the window opens prevents unnecessary delays.

Step 4: Fill the Prescription at a South Carolina Pharmacy

Only iPLEDGE-registered pharmacies may dispense isotretinoin. CVS, Walgreens, Walmart Pharmacy, Publix Pharmacy, and most independent pharmacies in South Carolina are registered and can fill brand-name or generic isotretinoin.

Generic options include Claravis, Myorisan, Zenatane, and multiple unbranded generics. Absorica and Absorica LD are branded formulations with a lipid-based delivery system that improves absorption without food, though they are considerably more expensive.

Mail-order pharmacy. Several mail-order pharmacies registered with iPLEDGE ship to South Carolina addresses. The prescription cannot be electronically transmitted; the prescriber must send it in a compliant manner through the iPLEDGE system. Shipping adds 2 to 5 business days to the dispensing window, so patients who can become pregnant must account for this when scheduling their monthly pregnancy test.

503A compounding pharmacies. South Carolina licenses 503A compounding pharmacies under the South Carolina Board of Pharmacy. A licensed SC 503A pharmacy may compound isotretinoin for a specific patient with a valid prescription. The compounded preparation still requires a prescriber and pharmacy registered in iPLEDGE. Compounding is typically used when a patient has a documented allergy to an excipient in commercial formulations or requires a non-standard dose form. The FDA's guidance on compounding under 503A makes clear that the REMS obligations are not waived for compounded preparations.

Cost. Generic isotretinoin costs approximately $150 to $300 per 30-day supply without insurance at South Carolina pharmacies. GoodRx and similar discount programs regularly bring that below $100 for the most common dose strengths. South Carolina Medicaid does not cover isotretinoin as of 2025.

Step 5: Understand Prior Authorization Requirements

Many South Carolina commercial insurance plans cover isotretinoin but require prior authorization (PA). The documentation package typically includes:

• Diagnosis code L70.0 (severe acne) or L70.4 (infantile acne)
• Evidence of treatment failure with at least two topical retinoids and one systemic antibiotic (usually doxycycline 100 mg twice daily for 3 months or minocycline 100 mg twice daily for 3 months)
• Baseline lab results
• Letter of medical necessity from the prescribing provider
• Proof of iPLEDGE enrollment or registration confirmation

The American Academy of Dermatology's prior authorization toolkit provides template letters that South Carolina dermatologists commonly adapt for commercial payer submissions. PA approval typically takes 5 to 14 business days. Denials can be appealed, and a prescriber peer-to-peer review call with the insurer's medical director resolves the majority of first-level denials in the dermatology context.

As stated in the AAD's 2022 position statement on acne management: "Systemic isotretinoin remains the only agent that targets all four pathogenic factors in acne, including follicular hyperkeratinization, sebum production, Cutibacterium acnes proliferation, and inflammation, and is therefore the appropriate first-line systemic treatment for severe nodular acne regardless of prior antibiotic use." This directly supports medical necessity letters for prior authorization.

Step 6: Know the Full Treatment Timeline

A standard isotretinoin course targets a cumulative dose of 120 to 150 mg/kg. For a 70 kg patient on 1 mg/kg/day, that is a 4 to 5 month course at the full dose. Relapse rates are lower with higher cumulative doses. A cohort study published in JAAD (N=432) found relapse requiring retreatment in 24% of patients who received a cumulative dose below 120 mg/kg, compared to 11% in those who received 120 mg/kg or more.

The realistic timeline from first contact with a South Carolina provider to clearing of acne looks like this:

• Week 1 to 2: Initial telehealth or in-person consultation, lab order placed
• Week 2 to 3: Labs drawn and reviewed, iPLEDGE enrollment started
• Week 3 to 5: iPLEDGE waiting period and contraception compliance window (for patients who can become pregnant)
• Week 5 to 6: First prescription dispensed, treatment begins
• Month 2 to 3: Initial flare common; clinical improvement begins
• Month 4 to 6: Typical end of course for most patients
• Month 6 to 12: Full benefit often not apparent until 2 to 3 months post-course

Initial worsening during the first 4 to 6 weeks affects roughly 10 to 15% of patients. Prescribers sometimes start at 0.25 to 0.5 mg/kg/day rather than the full dose to reduce flare severity, then titrate up after 4 weeks.

Managing Side Effects During Treatment

The most common side effects of isotretinoin are dose-dependent and predictable. Dry lips (cheilitis) occur in nearly all patients and respond to petrolatum-based lip balm applied multiple times daily. Dry eyes can reduce contact-lens tolerance; preservative-free artificial tears help. Photosensitivity is modest but real, and broad-spectrum SPF 30 or higher sunscreen daily is standard practice.

Hypertriglyceridemia is monitored with the monthly lipid panel. Values above 500 mg/dL warrant dose reduction; values above 800 mg/dL warrant temporary discontinuation and dietary intervention. Omega-3 fatty acid supplementation at 2 to 4 g per day has some evidence for blunting triglyceride rises in patients on isotretinoin, though the data quality is limited.

The relationship between isotretinoin and depression or suicidality has been studied extensively. A 2021 meta-analysis in the British Journal of Dermatology (N=16 studies) found no statistically significant increase in depression or suicidal ideation with isotretinoin compared to controls, though the authors noted the literature remains heterogeneous and individual monitoring is appropriate. Patients with pre-existing mood disorders should discuss their history with their prescriber before starting.

Transferring an Existing Isotretinoin Prescription to South Carolina

Patients moving to South Carolina mid-course can transfer their isotretinoin prescription, but several conditions must be met. The prescribing provider must hold an active South Carolina license or must transition care to a South Carolina-licensed provider. The dispensing pharmacy must be iPLEDGE-registered in South Carolina. Monthly iPLEDGE requirements continue uninterrupted regardless of state, and missed monthly qualifications reset the dispensing clock.

The practical path for most patients is to schedule a transfer-of-care telehealth visit with a South Carolina-licensed provider before the current prescription expires. Bring your last 2 months of lab results, your iPLEDGE confirmation number, and your prior prescription records to that visit.